Viewing Study NCT06964906


Ignite Creation Date: 2025-12-26 @ 4:03 PM
Ignite Modification Date: 2026-04-30 @ 7:21 PM
Study NCT ID: NCT06964906
Status: RECRUITING
Last Update Posted: 2025-05-11
First Post: 2025-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Therapy for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (NeoHunter)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2024-0367
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators